Premium
Using the Electroencephalographic (EEG) Fingerprint to Define the Clinical Pharmacodynamics (PD) of A Novel Opioid: Application to Remifentanil (REMI)
Author(s) -
Eaan T.D.,
Muir K.T.,
Stanski D.R.,
Shafer S.L.
Publication year - 1996
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.1996.16
Subject(s) - remifentanil , pharmacodynamics , electroencephalography , opioid , medicine , anesthesia , pharmacology , pharmacokinetics , psychiatry , propofol , receptor
Clinical Pharmacology & Therapeutics (1996) 59 , 129–129; doi: 10.1038/sj.clpt.1996.16
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom